Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-01-26

Clinical Trial Update: Magnesphere for Autonomic Alteration [NA]

View source ↗

Summary

The University of Oklahoma-sponsored clinical trial evaluating Magnesphere for autonomic alteration in heart failure with reduced ejection fraction has been wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Oklahoma | Conditions: Hart Failure With Reduced Ejection Fraction | NA | Status: WITHDRAWN